Histamine and IL-1 have been implicated in the pathogenesis of chronic inflammatory diseases, such as pulmonary allergic reactions and rheumatoid arthritis. We therefore investigated whether histamine modulated the synthesis of IL-1,8. Human PBMC were stimulated with IL-la (10 ng/ml) in the absence or presence of histamine (10-'-10-4 M). Histamine alone did not induce protein synthesis or mRNA accumulation for IL-1(3.
Introduction
Although mast cell activation is the initial event in acute allergic asthma, the event is often followed by a sustained inflammatory reaction that is characterized by a predominantly eosinophilic infiltration. Cross-linkage of the high affinity receptors for IgE (FcERI)' on mast cells induces release ofpreformed and newly synthesized mediators, such as histamine and arachidonic acid metabolites. However, in response to FcERI cross-linkage, mast cells also synthesize a wide array of cytokines, including IL-1, TNF-a, IL-3, IL-5, and GM-CSF ( 1-4) which, in turn, activate eosinophil functions. Stimulation of the low affinity receptors for IgE (FcERII) on monocytes also result in the production of IL-1A and TNF-a (5) . Therefore, cytokine synthesis by mast cells and monocytes may contribute to the onset of the late phase response.
IL-1 may play an important role in eosinophil accumulation during the late phase response. Recent evidence supports this concept since blockade of IL-1 by the naturally occurring IL-1 receptor antagonist (IL-l Ra) reduces eosinophil infiltration in lungs after inhalation of antigen by sensitized guinea pigs (6) . Related to these events, IL-1 upregulates the expression of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 on endothelial cells (7, 8) . Eosinophils constitutively express the integrin very late antigen-4 ( 9 ) that recognizes vascular cell adhesion molecule-1 (10) . Blockade of intracellular adhesion molecule-1 prevents both the eosinophil accumulation in the primate lung and the subsequent bronchial hyperreactivity to acetylcholine ( 11) . Moreover, high affinity receptors for human IL-3, IL-5 or GM-CSF are comprised of an a chain, specific for each cytokine, and of a common ,B chain ( 12, 13) . A role for IL-1 also exists in this response since IL-1 upregulates the expression of the ( chain ( 14) .
Since acute allergic asthma is characterized by both mast cell degranulation and IL-1 production, we investigated the effect ofhistamine on the synthesis ofIL-13 and IL-I Ra. Modulation by histamine ofgene expression and total cellular synthesis of IL-1,B and IL-1 Ra were studied in human PBMC stimulated with either LPS or IL-1 itself.
Methods
Human PBMC culture. Blood was drawn from healthy human volunteers who had not taken any histamine receptor antagonists or cyclooxygenase inhibitors for -2 wk. The study was approved by the Human Investigative Review Committee of The New England Medical Center Hospitals. PBMC were separated from heparinized blood by centrifugation on Ficoll-Hypaque (Ficoll Type 400; Sigma Chemical Co., St. Louis, MO, and Hypaque-M 90%; Winthrop Breon Laboratories, New York) gradients. Cells were washed twice in 0.15 M NaCl and resuspended at 5 x 106 cells/ml in ultrafiltered RPMI culture medium 1640 (Whittaker Bioproducts, Walkersville, MD) supplemented with 2 mM L-glutamine, 100 U/ml penicillin, and 100 ,ug/ml streptomycin (Gibco Laboratories, Grand Island, NY). PBMC (2.5 X 106 cells/ml in RPMI containing 1% heat-inactivated human AB serum) were stimulated with LPS from Escherichia coli 055:B5 ( 10 ng/ml; Sigma Chemical Co.) or human recombinant IL-la (10 ng/ml; kindly provided by Dr. P. Lomedico, Hoffmann-LaRoche Inc., Nutley, NJ) in the absence or presence ofeither histamine ( I0 -9-10-4 M, Sigma Chemical Co.) or PGE2 (0.1-1,000 ng/ml, Sigma Chemical Co. The histamine-mediated increase in IL-1p synthesis was reversed by cimetidine in a dose-dependent manner. The histamine ( o0-6 M)-mediated increase in IL-1(3 synthesis was reversed by cimetidine at 10-5 M (49% increase, n = 4, P> 0.05) and at 10-4 M (17% increase, n = 4, P > 0.05). However, cimetidine at 1o-6 M failed to reverse the histamine-mediated increase in IL-1: synthesis ( 104% increase, n = 4, P < 0.01).
PGE2 enhances IL-J(3 synthesis in IL-Ia-stimulated PBMC. Since activation of H2 receptors results in an increased activity ofadenylate cyclase ( 18), we next investigated whether PGE2, another activator of adenylate cyclase, enhanced IL-1(3 synthesis in IL-a-stimulated PBMC. PBMC stimulated with IL-la synthesized 0.46±0.12 ng/ml IL-I(3 (Fig. 3 ). PGE2 alone ( 1,000 ng/ml) did not induce IL-1,8 synthesis (data not shown). However, IL-a-induced synthesis of IL-1(3 was increased by PGE2 in a dose-dependent manner (Fig. 3 ). PGE2 at 10 ng/ml significantly enhanced IL-1,8 synthesis by 2.6-fold, whereas higher concentrations of PGE2 further increased IL- 13 synthesis. These observations further strengthen the concept that an increase in cAMP levels enhances self-induction of IL-1.
Since IL-1 induces PGE2 synthesis in PBMC, we next investigated whether the endogenous production ofPGE2 by IL-lastimulated PBMC contributed to the self-induction ofIL-1 and to the histamine-mediated increase in IL-1 synthesis. At a concentration of indomethacin, which completely inhibits prostaglandin synthesis ( 19), we observed a significant reduction in IL-la-induced IL-1( synthesis (51% inhibition, P < 0.05) (Fig. 4) . However, indomethacin did not affect the histaminemediated increase in IL-1(3 synthesis by IL-la-stimulated PBMC (97% increase, P < 0.05 [untreated cells] vs 99% increase, P < 0.05 [indomethacin-treated cells], n = 4). Indomethacin alone did not induce IL-1( synthesis (data not shown).
Histamine enhances and sustains IL-1,8 mRNA levels in IL-ia-stimulated PBMC. Unstimulated, cultured PBMC did not express detectable levels of IL-1( mRNA (Fig. 5 and 6 ). Histamine ( I0 -M) strongly enhanced both IL-1(3 protein and IL-1(3 mRNA levels in IL-I a-stimulated PBMC (Fig. 5 ). Histamine alone did not induce mRNA accumulation for IL-1( (data not shown). IL-1( mRNA reached peak levels within the first 8 h after exposure to IL-1 a and gradually returned to basal levels ( We then investigated whether histamine modified the kinetics ofIL-I Ra synthesis in PBMC stimulated with either LPS or IL-1 a, thus reducing self-induction ofIL-1. As shown in Fig.  9 , histamine ( I0-5 M) did not modify the kinetics of IL-lRa synthesis in PBMC stimulated with either IL-la (A) or LPS (B).
Discussion
In these studies, we demonstrate that histamine enhances IL-la-induced IL-Ip synthesis via activation of histamine H2 receptors. IL-1p synthesis was increased two to threefold at Time (h) Figure 9 . Effect of histamine on the kinetics of IL-IRa synthesis. PBMC were stimulated with either IL-la ( 10 ng/ml, A) or LPS (10 ng/ml, B) in the ab- histamine concentrations from 10-6 to 10-4 M. Histamine increased and sustained the steady-state mRNA levels for IL-13 in IL-la-stimulated PBMC, but reduced the half-life of IL-1(3 mRNA in the same cells, suggesting that the histamine-mediated increase in IL-13 synthesis is a transcriptional event.
Histamine enhanced self-induction of IL-I at concentrations as low as o0-6 M. Histamine concentrations in the micromolar range have been reported to suppress the LPS-induced synthesis of TNF-a in PBMC (22) , to reduce the LPS-induced synthesis of IL-1 in human monocytes purified by adherence (23) and to inhibit the synthesis of IL-2 and IFN-y in PBMC stimulated with Staphylococcal Enterotoxin A (24) . Thus, the increase in self-induction of IL-1 occurs at histamine concentrations required to observe other immunomodulatory effects of histamine. However, the biological relevance of these concentrations remains uncertain, since histamine levels in tissue have yet to be determined. It is indeed difficult to evaluate histamine levels in tissue after mast cell degranulation because of the rapid degradation of histamine. Nevertheless, based on the histamine concentrations reached in vitro after basophil degranulation (25) vented the histamine-mediated increase in self-induction of IL-1. Thus, histamine enhances IL-13 synthesis via activation of H2 receptors. However, neither cimetidine nor ranitidine modified the IL-l a-induced IL-1(3 synthesis in the absence of exogenous histamine, ruling out a contribution of endogenous histamine released by contaminating basophils in our experimental conditions. To strengthen further the concept that an increase in cAMP levels enhances self-induction of IL-1, we investigated whether PGE2, another activator ofadenylate cyclase, increased self-induction of IL-1. PGE2 itself did not induce IL-1(3 synthesis but enhanced IL-1(3 synthesis in IL-la-stimulated PBMC. Similarly, PGE2 has been reported to increase the IL-l(3-induced synthesis of IL-I a in PBMC (29) . In support of this observation, indomethacin, a cyclooxygenase inhibitor, reduced the IL-la-induced synthesis of IL-1(3. Of critical importance to this finding is the fact that IL-I increases both enzymatic activity and gene expression of cyclooxygenase (30) (31) (32) . Thus, endogenous production of PGE2 by IL-1-stimulated PBMC likely explains the suppressive effect of indomethacin on selfinduction of IL-1. Recently, IL-I Ra has been shown to exert beneficial effects in experimental arthritis (33) . Deleterious effects of prostaglandins, PGE2 in particular, may contribute to the worsening of inflammatory diseases since PGE2 increases self-induction of IL-1. Thus, the beneficial effects of nonsteroidal antiinflammatory drugs in arthritis may result, in part, from a suppression of a positive regulatory effect of PGE2 on IL-I synthesis. (39) . In both reports, elevated cAMP levels did not alter the stability of IL-1(3 mRNA, but increased the transcriptional rate of the IL-1( gene. The striking similarity in the mechanisms of upregulation of IL-1(3 gene expression and protein synthesis lead us to postulate that an increase in IL-i synthesis in LPS-stimulated monocytes is caused in part by an increase in self-induction ofIL-1. Both the PGE2-mediated increase in self-induction of IL-I and the reduction of self-induction of IL-I by indomethacin support our hypothesis. Interestingly, PGE2 or dibutyryl cAMP also enhances mRNA accumulation and protein synthesis for IL-1(3 in PMA-stimulated human monocytes (37) and myeloid leukemia cells (40) . In agreement with our hypothesis, self-induction of IL-I largely (70%) contributes to PMA-induced IL-1( synthesis (20) .
Previous reports indicate that IL-i may synergize with cAMP-increasing agents (41, 42 Such an indirect effect of histamine on IL-I -induced IL-I gene expression is further supported by the absence of a cAMP re-sponsive element motif in the 5' regulatory sequences of the IL-fI gene (39) .
Our results expand on those of others in that we measured total IL-I(3 synthesis using a specific immunoreactive assay. Unlike bioassays for IL-1p3, the immunoassay is not affected by the presence of IL-1 Ra. Reduction in IL-1 Ra synthesis may contribute to an increase in self-induction ofIL-1 in LPS-stimulated PBMC. However, a specific radioimmunoassay for IL-1 Ra revealed that histamine failed to affect the synthesis of IL-1 Ra induced by either LPS or IL-I a. Furthermore, histamine did not accelerate the synthesis of IL-1 Ra over a time period of 32 h. Thus, histamine is unlikely to increase self-induction of IL-1 in LPS-stimulated PBMC by affecting the endogenous synthesis of IL-1 Ra. Finally, the lack of effect of histamine on IL-la-induced IL-1 Ra synthesis provides additional evidence that IL-13 and IL-1 Ra, two members of the same cytokine gene family (45) , are differentially regulated (16, 46 
